BioWorld’s Tom Wall interviewed BIO’s Alan Eisenberg (subscription required) on what attendees can expect at this week’s BIO India International Partnering Conference.
Interest in India has been strong and attendance at the conference is expected to surpass last year’s event. The population forecasted to grow in the coming years, combined with significant disease burden is a draw for many companies seeking business development and partnering opportunities.
BIO India will feature keynote speakers Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals; Aaron Schacht, Executive Director and COO, Global External R&D, Eli Lilly & Company; Vivek Mohan, President of Services at Alcatel-Lucent; and Cartikeya Reddy, Senior Vice-President and Head, Biologics, Dr. Reddy’s Laboratories Ltd.
Panel sessions include a case study discussion on the Pfizer-Biocon deal, and sessions focused on outsourcing and the long-term prospects of doing business in India.